301281 科源製藥
按盤價 
22.880 +0.190 (+0.837%)
22.880 +0.190 (+0.837%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.606 | 8.325 | 19.202 | 20.236 | 22.330 |
| 總資產報酬率 ROA (%) | 1.448 | 7.262 | 15.071 | 15.358 | 14.320 |
| 投入資產回報率 ROIC (%) | 1.582 | 8.154 | 18.635 | 19.474 | 18.535 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.482 | 47.252 | 40.936 | 42.101 | 50.057 |
| 營業利潤率 (%) | 16.700 | 17.900 | 22.167 | 21.341 | 21.417 |
| 息稅前利潤/營業總收入 (%) | 15.244 | 16.731 | 21.581 | 21.427 | 22.814 |
| 淨利潤/營業總收入 (%) | 14.714 | 17.212 | 20.611 | 18.573 | 18.703 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 93.923 | 83.434 | 96.574 | 92.525 | 91.654 |
| 價值變動淨收益/利潤總額(%) | 6.708 | 15.983 | 0.000 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -5.163 | -0.478 | 0.131 | 0.107 | 3.045 | 償債能力分析 |
| 流動比率 (X) | 6.617 | 7.907 | 2.617 | 1.836 | 1.771 |
| 速動比率 (X) | 5.825 | 6.935 | 1.987 | 1.056 | 1.060 |
| 資產負債率 (%) | 10.110 | 9.451 | 20.261 | 22.971 | 25.494 |
| 帶息債務/全部投入資本 (%) | -0.484 | -0.520 | -1.119 | -1.590 | 0.655 |
| 股東權益/帶息債務 (%) | -20,357.579 | -18,929.749 | -8,633.711 | -6,137.068 | 14,441.015 |
| 股東權益/負債合計 (%) | 888.494 | 958.081 | 393.551 | 335.331 | 292.245 |
| 利息保障倍數 (X) | -23.969 | -15.447 | -35.060 | 340.459 | 31.525 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 36.825 | 32.438 | 24.031 | 17.141 | 29.257 |
| 存貨周轉天數 (天) | 109.037 | 134.162 | 106.221 | 116.260 | 129.268 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 02/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
